CME
Advanced Practice Perspectives on CDK 4/6 Inhibitors: Paving the Way for HR+, HER2-Negative Early Breast Cancer
July 27, 2021
Host: Kristi K. Orbaugh, MSN, NP, AOCN®
Guest: Val R. Adams, PharmD, FCCP, BCOP, FHOPA
Guest: Theresa W. Gillespie, PhD, MA, RN, FAAN
Endocrine therapy is currently the cornerstone of treatment for advanced hormone receptor–positive (HR+) breast
Visit Podcast Website
RSS Podcast Feed
Subscribe
Share
Add to MyCast
Gain access to Blubrry tools that help build your podcast, including free podcast stats!